Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response

Early biomarkers of therapeutic responses can help optimize the treatment of metastatic colorectal cancers (mCRC). In this prospective exploratory study, we examined serial changes of plasma-circulating tumor DNA (ctDNA) in 41 mCRC patients receiving first-line chemotherapies and tested its associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Ning, Sun, Zhao, Gao, Xin, Cheng, Yuejuan, Zhou, Yanping, Shen, Chunying, Chen, Wei, Wang, Xueliang, Shi, Rong, Li, Nan, Zhou, Jianfeng, Bai, Chunmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536571/
https://www.ncbi.nlm.nih.gov/pubmed/31164904
http://dx.doi.org/10.3389/fgene.2019.00470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536571/
https://www.ncbi.nlm.nih.gov/pubmed/31164904
http://dx.doi.org/10.3389/fgene.2019.00470

Ejemplares similares